Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2019

Aug 14, 2019

BUY
$19.05 - $41.04 $1.67 Million - $3.59 Million
87,500 New
87,500 $1.76 Million
Q3 2018

Nov 14, 2018

SELL
$35.05 - $43.5 $1.69 Million - $2.1 Million
-48,300 Closed
0 $0
Q2 2018

Aug 14, 2018

SELL
$35.15 - $51.45 $2.66 Million - $3.89 Million
-75,600 Reduced 61.02%
48,300 $1.78 Million
Q1 2018

May 15, 2018

BUY
$18.0 - $48.35 $2.23 Million - $5.99 Million
123,900 New
123,900 $4.83 Million

Others Institutions Holding ATRA

About Atara Biotherapeutics, Inc.


  • Ticker ATRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 94,362,304
  • Market Cap $781M
  • Description
  • Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferat...
More about ATRA
Track This Portfolio

Track Jefferies Group LLC Portfolio

Follow Jefferies Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Group LLC with notifications on news.